Evan G. Dick
Corporate Officer/Principal chez CONTEXT THERAPEUTICS INC.
Profil
Evan G.
Dick is a Scientific Advisor at Context Therapeutics, Inc. He previously worked as the Chief Executive Officer at Kereos, Inc., Director at Context Therapeutics LLC, Vice President-Operations at Fulcrum Pharmaceuticals, Inc., Senior Vice President-Business Development at Ceptaris Therapeutics, Inc., SVP-Discovery Medicine & Operations at Ception Therapeutics, Inc., Senior Vice President-Discovery Medicine at Aclaris Therapeutics, Inc., Head-Ophthalmology Research & Development at G.D.
Searle & Co., Inc., Vice President & General Manager at Medstrategy, Inc., Chief Operating Officer at Cytotaxis, Inc., Senior Vice President-Chemistry at Ralexar Therapeutics, Inc., and Partner at NeXeption LLC.
He completed his undergraduate degree at Cornell University and received his doctorate from the State University of New York at Buffalo in 1978.
Dr. Dick's current job is a Scientific Advisor at Context Therapeutics, Inc.
Postes actifs de Evan G. Dick
| Sociétés | Poste | Début |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Corporate Officer/Principal | - |
Anciens postes connus de Evan G. Dick
| Sociétés | Poste | Fin |
|---|---|---|
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Corporate Officer/Principal | 01/01/2013 |
Ception Therapeutics, Inc.
 Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Directeur des opérations | 01/04/2010 |
Ralexar Therapeutics, Inc.
 Ralexar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ralexar Therapeutics, Inc. operates as an pharmaceutical company that develops topical and systemic therapies. The company was founded in January 2014 and is headquartered in Wayne, PA. | Corporate Officer/Principal | - |
NeXeption LLC
 NeXeption LLC Pharmaceuticals: MajorHealth Technology NeXeption LLC operates as a biopharmaceutical assets management firm. It provides biopharmaceutical management services, product opportunities, management expertise and funding. The firm offers an alternative pipeline development path for non-progressing assets or science and provide the appropriate resources and access to capital to advance assets from concept through commercialization. The company was founded by Stephen A. Tullman, Kamil Ali-Jackson and Neal S. Walker in 2011 and is headquartered in Malvern, PA. | Corporate Officer/Principal | - |
| ACLARIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Evan G. Dick
| Cornell University | Undergraduate Degree |
| State University of New York at Buffalo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| CONTEXT THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
| Fulcrum Pharmaceuticals, Inc. | Health Technology |
Kereos, Inc.
 Kereos, Inc. Pharmaceuticals: MajorHealth Technology Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO. | Health Technology |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
| Medstrategy, Inc. | |
| Cytotaxis, Inc. | |
NeXeption LLC
NeXeption LLC Pharmaceuticals: MajorHealth Technology NeXeption LLC operates as a biopharmaceutical assets management firm. It provides biopharmaceutical management services, product opportunities, management expertise and funding. The firm offers an alternative pipeline development path for non-progressing assets or science and provide the appropriate resources and access to capital to advance assets from concept through commercialization. The company was founded by Stephen A. Tullman, Kamil Ali-Jackson and Neal S. Walker in 2011 and is headquartered in Malvern, PA. | Health Technology |
Ralexar Therapeutics, Inc.
Ralexar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ralexar Therapeutics, Inc. operates as an pharmaceutical company that develops topical and systemic therapies. The company was founded in January 2014 and is headquartered in Wayne, PA. | Health Technology |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
